Related Experiment Video
Updated: Jul 26, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Quality of life in treated and never-treated schizophrenic patients
C A Green1, D S Fenn, D Moussaoui
1Kaiser Permanente Center for Health Research, Portland, Oregon, USA.
Objective:
To evaluate quality of life (QOL) among treated and never-treated schizophrenic patients.
Method:
QOL ratings were obtained for (a) 112 Moroccan participants with schizophrenia who had never received neuroleptic medications, (b) matched samples of chronically-medicated schizophrenic patients in Morocco and the United States and (c) matched community controls in both countries.
Results:
QOL ratings were generally higher for US groups, although Moroccan controls obtained higher ratings than US controls for some domains. QOL ratings were higher for controls compared to patients within each country, although US patients' scores were similar to controls on some dimensions. We found no differences between treated and untreated Moroccan patients for any QOL domain, although relationships among predictors were different.
Conclusion:
Within the context of Moroccan culture, benefits of medications alone are not evident in QOL scores. QOL appears to be a complex construct influenced by different factors within each of the groups studied.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Schizophrenia
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Psychological and Sociocultural Causes of Schizophrenia
Drug Therapy
Antianxiety Medications